Epilepsy and Alzheimer's Disease: Ubiquitous Entities Subject to the Same Cosmic Forces but on Different Astral Planes

Comment

Cynthia L Harden. Epilepsy Curr. 2018 Sep-Oct.

. 2018 Sep-Oct;18(5):295-297.

doi: 10.5698/1535-7597.18.5.295.

No abstract available

Comment on

Silent hippocampal seizures and spikes identified by foramen ovale electrodes in Alzheimer's disease.
Lam AD, Deck G, Goldman A, Eskandar EN, Noebels J, Cole AJ. Lam AD, et al. Nat Med. 2017 Jun;23(6):678-680. doi: 10.1038/nm.4330. Epub 2017 May 1. Nat Med. 2017. PMID: 28459436 Free PMC article.

1. Tai XY, Koepp M, Duncan JS, Fox N, Thompson P, Baxendale S, Liu JYW, Reeves C, Michalak Z, Thom M. Hyperphosphorylated tau in patients with refractory epilepsy correlates with cognitive decline: A study of temporal lobe resections. Brain. 2016;139(pt 9):2441–2455. - PMC - PubMed
1. Gheyara A, Ponnusamy R, Djukic B, Craft RJ, Ho K, Guo W, Finucane MM, Sanchez PE, Mucke L. Tau reduction prevents disease in a mouse model of Dravet syndrome. Ann Neurol. 2014;76:443–456. - PMC - PubMed
1. Di J, Cohen LS, Corbo CP, Phillips GR, El Idrissi A, Alonso AD. Abnormal tau induces cognitive impairment through two different mechanisms: Synaptic dysfunction and neuronal loss. Sci Rep. 2016;18:20833. - PMC - PubMed
1. Gomez-Isla T, West HL, Rebeck GW, Harr SD, Growdon JH, Locascio JJ, Perls TT, Lipsitz LA, Hyman BT. Clinical and pathological correlates of apolipoprotein E epsilon 4 in Alzheimer's disease. Ann Neurol. 1996;39:62–70. - PubMed
1. Kauffman MA, Consalvo D, Moron DG, Lereis VP, Kochen S. ApoE 4 genotype and the age at onset of temporal lobe epilepsy: A case–control study and meta-analysis. Epilepsy Res. 2010;90:234–239. - PubMed